Surrozen, Inc. (SRZNW)South San Francisco, United States | NasdaqCM
0.02 USD
+0.00
(1.596%)
⇧
(April 17, 2026, 12:42 p.m.
EDT)
Short-term: ☆☆☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:57 a.m. EDT
High-risk speculative asset with deteriorating fundamentals, negative cash flow, and zero dividend yield; weak forecasting signals and 52-week lows suggest strong sell or avoid signal. |
| Attribute | Value |
|---|---|
| Revenue per Share | 0.465 |
| Beta | 0.52 |
| Previous Name | Consonance-HFW Acquisition Corp. |
| Website | https://www.surrozen.com |
| Attribute | Value |
|---|---|
| Address1 | 171 Oyster Point Boulevard |
| Address2 | Suite 400 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 0.517 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | -19.209 |
| City | South San Francisco |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0191 |
| Current Ratio | 9.22 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0191 |
| Day Low | 0.0188 |
| Display Name | Surrozen |
| Ebitda | -41,555,000 |
| Ebitda Margins | 0.0 |
| Eps Trailing Twelve Months | -5.695 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0191 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.0188 |
| Fifty Two Week Low Change | 0.0002999995 |
| Fifty Two Week Low Change Percent | 0.01595742 |
| Fifty Two Week Range | 0.0188 - 0.0191 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,772,807,400,000 |
| Float Shares | 5,421,151 |
| Free Cashflow | -16,856,500 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 44 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -25,888,000 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,021-08-12 |
| Language | en-US |
| Long Business Summary | Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6 for the treatment of DME/wet AMD/uveitic macular edema; SZN-113 to treat Fuchs' endothelial corneal dystrophy and geographic atrophy; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California. |
| Long Name | Surrozen, Inc. |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_401948183 |
| Name Change Date | 2,026-04-19 |
| Net Income To Common | -242,026,000 |
| Open | 0.009 |
| Operating Cashflow | -30,244,000 |
| Operating Margins | -23.9375 |
| Phone | 650 489 9000 |
| Prev Name | Consonance-HFW Acquisition Corp. |
| Previous Close | 0.0188 |
| Price Hint | 4 |
| Price To Book | -0.0009943255 |
| Profit Margins | 0.0 |
| Quick Ratio | 9.008 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0002999995 |
| Regular Market Change Percent | 1.5957421 |
| Regular Market Day High | 0.0191 |
| Regular Market Day Low | 0.0188 |
| Regular Market Day Range | 0.0188 - 0.0191 |
| Regular Market Open | 0.009 |
| Regular Market Previous Close | 0.0188 |
| Regular Market Price | 0.0191 |
| Regular Market Time | 1,776,444,164 |
| Regular Market Volume | 2,992 |
| Return On Assets | -0.35746 |
| Revenue Growth | -0.194 |
| Revenue Per Share | 0.465 |
| Sand P52 Week Change | 0.38150132 |
| Sector | |
| Sector Key | |
| Short Name | Surrozen, Inc. Warrant |
| Source Interval | 15 |
| State | CA |
| Symbol | SRZNW |
| Total Cash | 89,245,000 |
| Total Cash Per Share | 7.769 |
| Total Debt | 6,639,000 |
| Total Revenue | 3,477,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -5.695 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 2,992 |
| Website | https://www.surrozen.com |
| Zip | 94,080 |